Next Article in Journal
Targeting Emerging Pathogenic Mechanisms by Natural Molecules as Potential Therapeutics for Neurodegenerative Diseases
Next Article in Special Issue
Olaparib Conjugates with Selenopheno[3,2-c]quinolinone Inhibit PARP1 and Reverse ABCB1-Related Multidrug Resistance
Previous Article in Journal
Design, Preparation and Evaluation of Supramolecular Complexes with Curcumin for Enhanced Cytotoxicity in Breast Cancer Cell Lines
Previous Article in Special Issue
Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(11), 2286; https://doi.org/10.3390/pharmaceutics14112286
Action Date Notes Link
article pdf uploaded. 25 October 2022 13:35 CEST Version of Record https://www.mdpi.com/1999-4923/14/11/2286/pdf-vor
article xml file uploaded 9 November 2022 10:29 CET Original file -
article xml uploaded. 9 November 2022 10:29 CET Update https://www.mdpi.com/1999-4923/14/11/2286/xml
article pdf uploaded. 9 November 2022 10:29 CET Updated version of record https://www.mdpi.com/1999-4923/14/11/2286/pdf
article html file updated 9 November 2022 10:31 CET Original file -
article html file updated 28 February 2023 19:46 CET Update -
article html file updated 2 March 2023 00:17 CET Update https://www.mdpi.com/1999-4923/14/11/2286/html
Back to TopTop